MedDay Pharmaceuticals
FranceEntry
2016
Hold
5yr
Exit
2021
Who owns MedDay Pharmaceuticals?
MedDay Pharmaceuticals was owned by Andera Partners through BioDiscovery 4 (2013 vintage) from 2016 to 2021, exited via Trade Sale.
Hand-verified · updated 2026-04-21
Exit Type
Trade Sale
Buyer
–
MOIC
–
Exit Year
2021
More from BioDiscovery 4
Other portfolio companies in the same fund.
UK
US
SpainMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track MedDay Pharmaceuticals
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy MedDay Pharmaceuticals?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on MedDay Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue